EntityQ420882· pop 15· linked from 1,581 articles

fonturacetam

Phenylpiracetam, also known as fonturacetam () and sold under the brand names Phenotropil, Actitropil, and Carphedon among others, is a stimulant and nootropic medication used in Russia and certain other Eastern European countries in the treatment of cerebrovascular deficiency, depression, apathy, attention, and memory problems, among other indications. It is also used in Russian cosmonauts to improve physical, mental, and cognitive abilities. The drug is taken by mouth.

Key facts

Drug.Verifiedfields: verified
Drug.Watchedfields: verified
Drug.INN: Fonturacetam
Drug.verifiedrevid: 447920554
Drug.image: Phenylpiracetam.svg
Drug.image_class: skin-invert-image
Drug.width: 125px
Drug.image2: Phenylpiracetam.png
Drug.image_class2: bg-transparent
Drug.width2: 125px
Drug.tradename: Phenotropil, Carphedon, Actitropil, others
Drug.pregnancy_category: Unknown
Drug.legal_AU: S4
Drug.legal_US: Unapproved drug; use in dietary supplements, food, or medicine is unlawful.
Drug.legal_status: RU: Rx-only
Drug.routes_of_administration: By mouth
Drug.bioavailability: ~100%
Drug.metabolism: Not metabolized

via Wikipedia infobox

Article

23 sections

Contents

Medical uses
Available forms
Contraindications
Side effects
Overdoses
Pharmacology
Pharmacodynamics
Dopamine reuptake inhibitor
Other actions
Animal studies
Pharmacokinetics
Chemistry
Derivatives
History
Society and culture
Availability
Manufacturer
Doping in sport
Research
See also
References
Further reading
External links

Side effects of phenylpiracetam include sleep disturbances among others. The mechanism of action of phenylpiracetam was originally unknown. However, it was discovered that (R)-phenylpiracetam is a selective atypical dopamine reuptake inhibitor in 2014. In addition, phenylpiracetam interacts with certain nicotinic acetylcholine receptors. Chemically, phenylpiracetam is a racetam and phenethylamine and is structurally related to piracetam.